NASDAQ: CMMB
Chemomab Therapeutics Revenue

Chemomab Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CMMB annual revenue was $0.0, with N/A growth year-over-year.

CMMB revenue history

Current Revenue
$0.0
Current Earnings
-$14.4M
Current Profit Margin
0%

Be the first to know when CMMB announces revenue.

CMMB Revenue History By Year

CMMB Yearly RevenueCMMB RevenueCMMB ChangeCMMB Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Chemomab Therapeutics Revenue FAQ

What was CMMB's revenue last quarter?

On Invalid Date, Chemomab Therapeutics (NASDAQ: CMMB) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Chemomab Therapeutics's revenue was $0.00.

What was Chemomab Therapeutics's revenue in 2023?

Chemomab Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Chemomab Therapeutics make in a day?

Based on Chemomab Therapeutics annual revenue for the past five years, CMMB makes an average of $0.00 per day.

What was Chemomab Therapeutics's annual revenue growth in the past year?

As of Q1 2025, Chemomab Therapeutics's revenue has grown null year over year. Chemomab Therapeutics's revenue in the past year totaled $0.00.

How much does Chemomab Therapeutics make in a year?

Chemomab Therapeutics's revenue by year for the past five years is:
  • Chemomab Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Chemomab Therapeutics's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Chemomab Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Chemomab Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
  • Chemomab Therapeutics's annual revenue for 2019 was $0.00, a N/A decrease from 2018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.